Industry News
Pharma ExCellThera's novel blood cancer stem cell therapy Zemcelpro earns EU nod
A new treatment option for certain patients with blood cancers has passed muster with the European Commission (EC).
Zemcelpro, made by ExCellThera subsidiary Cordex Biologics, is a one-time cell therapy meant to offer a curative treatment for those with hematological malignancies (also known as blood cancers) who don’t have access to necessary donor cells.
Discover What's Happening
Business Sustainability Updates, Straight to Your Inbox
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
